Glucagonoma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Mahshid)
 
(12 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Glucagonoma}}
{{Glucagonoma}}
{{CMG}}{{AE}}{{PSD}}
{{CMG}}; {{AE}} {{PSD}}, {{MAD}}
==Overview==
==Overview==
Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was first to report a case of [[hyperglucagonemia]] associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]].
Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was the first to report a case of [[hyperglucagonemia]] associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]].


==Historical Perspective==
==Historical Perspective==
*In 1942, glucagonoma has been first described by Becker.
*In 1942, glucagonoma was first described by Becker.
*Between 1942 and 1966, many authors tried to make associations between high level of [[glucagon]] and [[Skin eruption|skin eruptions]].
*Between 1942 and 1966, many authors tried to make associations between high level of [[glucagon]] and skin eruptions.
*In 1966, The first well-documented case of glucagonoma was reported by McGavran in a female with [[skin lesions]] and [[glucose intolerance]]. The author was the first to note a correlation between [[skin lesions]] and [[Islet-cell tumor|islet-cell tumors]].<ref name="pmid22970401">{{cite journal| author=Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A| title=Necrolytic migratory erythema as the first manifestation of glucagonoma. | journal=Case Rep Surg | year= 2012 | volume= 2012 | issue=  | pages= 974210 | pmid=22970401 | doi=10.1155/2012/974210 | pmc=PMC3434377 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22970401  }} </ref>
*In 1966, The first well-documented case of glucagonoma was reported by McGavran in a female with [[skin lesions]] and [[glucose intolerance]]. The author was the first to describe a correlation between [[skin lesions]] and [[Islet cell tumor|islet-cell tumors]].<ref name="pmid22970401">{{cite journal| author=Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A| title=Necrolytic migratory erythema as the first manifestation of glucagonoma. | journal=Case Rep Surg | year= 2012 | volume= 2012 | issue=  | pages= 974210 | pmid=22970401 | doi=10.1155/2012/974210 | pmc=PMC3434377 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22970401  }} </ref>
*In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]].<ref name="pmid22970401" />
*In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]].<ref name="pmid22970401" />


Line 14: Line 14:
{{reflist|2}}
{{reflist|2}}


[[Category:Disease]]
{{WH}}
[[Category:Types of cancer]]
{{WS}}
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
 
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
[[Category:Oncology]]
{{WikiDoc Sources}}
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Surgery]]

Latest revision as of 01:48, 27 November 2017

Glucagonoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Glucagonoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glucagonoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glucagonoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glucagonoma historical perspective

CDC on Glucagonoma historical perspective

Glucagonoma historical perspective in the news

Blogs on Glucagonoma historical perspective

Directions to Hospitals Treating Glucagonoma

Risk calculators and risk factors for Glucagonoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]

Overview

Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was the first to report a case of hyperglucagonemia associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as necrolytic migratory erythema.

Historical Perspective

References

  1. 1.0 1.1 Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A (2012). "Necrolytic migratory erythema as the first manifestation of glucagonoma". Case Rep Surg. 2012: 974210. doi:10.1155/2012/974210. PMC 3434377. PMID 22970401.

Template:WH Template:WS